AVITA Medical, Inc. RCEL
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- +352.75%
- 1 year
- +306.77%
5D +0.30 (+1.91%)
- Market cap
- 494.96M
- Revenue (ttm)
- 60.04M
- Profit margin
- -95.47%
- EPS (ttm)
- -1.17
- Shares out
- 26.22M
- Forward P/E
- -14.33
- YTD return
- +352.75%
- 1-year return
- +306.77%
- 50-day average
- 11.87
- Volume
- 386.99K
- Avg volume
- 415.69K
- Open
- 15.76
- Previous close
- 15.99
- Day's range
- 15.51 – 16.26
- 52-week range
- 3.22 – 18.43
- Beta
- 1.54
- Analysts
- Buy
- Price target
- 16.81 (+7.6%)
Key statistics
- 200-day average
- 10.61
- Enterprise value
- 309.80M
- Price / sales
- 5.13
- Price / book
- 25.21
- Revenue growth
- 43.20%
- Free cash flow
- -33.68M
- Total cash
- 44.41M
- Total debt
- 45.63M
- Return on equity
- -152.44%
- Short % of float
- 4.49%
Fundamental scorecard
5 of 25 checks passed on RCEL’s reported financials
5of 25 checks passed
- Value 0 of 5
- Growth 3 of 5
- Profitability 1 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.42 | -0.62 | -0.20 | -47.62% |
| Aug 8, 2024 | Jun 1, 2024 | -0.59 | -0.60 | -0.01 | -1.69% |
| May 13, 2024 | Mar 1, 2024 | -0.26 | -0.73 | -0.47 | -180.77% |
| Feb 22, 2024 | Dec 1, 2023 | -0.34 | -0.28 | +0.06 | +17.65% |
| Nov 9, 2023 | Sep 1, 2023 | -0.53 | -0.34 | +0.19 | +35.85% |
| Aug 10, 2023 | Jun 1, 2023 | -0.34 | -0.41 | -0.07 | -20.59% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | Piper Sandler | reit | Neutral | Neutral |
| Aug 9, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| May 14, 2024 | Piper Sandler | down | Overweight | Neutral |
| May 14, 2024 | Cantor Fitzgerald | main | Overweight | Overweight |
| Apr 11, 2024 | BTIG | down | Buy | Neutral |
| Feb 23, 2024 | Piper Sandler | reit | Overweight | Overweight |
About AVITA Medical, Inc.
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- avitamedical.com
News
TJX Posts Strong Q3 Sales, Joins BellRing Brands, Bullish And Other Big Stocks Moving Higher On Wednesday AVITA Medical Reports Complete 6-Month Cohealyx I Study Results In Full-Thickness Wounds; Study Met Its Primary Endpoint
AVITA Medical Reports Complete Cohealyx I Data in Full-Thickness Wounds Showing Earlier Graft Readiness and Six-Month Healing Outcomes
AVITA Medical Shares Rose 329% In A Year, Medicare Resets Its Billing Codes Next TD Cowen Maintains Buy on AVITA Medical, Raises Price Target to $22
Lake Street Maintains Buy on AVITA Medical, Raises Price Target to $20
Texas Roadhouse To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Friday BTIG Maintains Buy on AVITA Medical, Raises Price Target to $21
AVITA Medical Q3 2026 Earnings Call Transcript AVITA Medical Q3 EPS $(0.20) Beats $(0.22) Estimate, Sales $25.862M Beat $22.200M Estimate
Your note
Sign in to keep a note on RCEL — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.10% | 1,860,519 | 21.86M | Sep 29, 2024 |
| Vanguard Group Inc | 5.41% | 1,417,672 | 16.66M | Sep 29, 2024 |
| Geode Capital Management, LLC | 2.27% | 594,436 | 6.98M | Sep 29, 2024 |
| State Street Corporation | 1.98% | 519,997 | 6.11M | Sep 29, 2024 |
| Essex Investment Management Co LLC | 0.88% | 231,094 | 2.72M | Sep 29, 2024 |
| Northern Trust Corporation | 0.83% | 216,467 | 2.54M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.05% | 800,719 | 9.41M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.50% | 656,684 | 7.72M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.48% | 389,203 | 4.57M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 1.00% | 262,420 | 3.08M | Aug 30, 2024 |
| iShares Russell 2000 Growth ETF | 0.88% | 231,647 | 2.72M | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.55% | 145,150 | 1.71M | Oct 30, 2024 |
